newsAlzheimer’s senescent cell combination therapy presents promise7 September 2023 | By Catherine Eckford (European Pharmaceutical Review)Evidence from a Phase I trial suggests that the tyrosine kinase inhibitor dasatinib in combination with quercetin clears amyloid from the brain and lowers inflammation in the blood.
newsCHMP meeting highlights, January 202228 January 2022 | By Hannah Balfour (European Pharmaceutical Review)The EMA’s Human Medicines Committee (CHMP) recommended approval of Paxlovid for COVID-19 and a new gene therapy for large B-cell lymphomas.
newsMouse model shows success of senolytic drugs in reversing senescent cell damage11 July 2018 | By European Pharmaceutical ReviewAn NIH-funded study has demonstrated that a combination of senolytic drugs can successfully reverse cell senescence in mice; providing potential avenue for future age-related treatment study.
